AbCellera Biologics Inc.·4

Dec 9, 5:55 PM ET

Stimart Tryn 4

4 · AbCellera Biologics Inc. · Filed Dec 9, 2021

Insider Transaction Report

Form 4
Period: 2021-12-07
Stimart Tryn
Chief Legal Officer
Transactions
  • Award

    Share Option (right to buy)

    2021-12-07+270,6802,311,480 total
    Exercise: $14.55Exp: 2031-12-07Common Shares (270,680 underlying)
Holdings
  • Common Shares

    250
  • Common Shares

    (indirect: By Spouse)
    250
Footnotes (1)
  • [F1]The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 7, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION